Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
28.04
-0.02 (-0.07%)
At close: Mar 31, 2025, 4:00 PM
27.46
-0.58 (-2.07%)
After-hours: Mar 31, 2025, 5:47 PM EDT
Perrigo Company Revenue
In the year 2024, Perrigo Company had annual revenue of $4.37B, down -6.06%. Perrigo Company had revenue of $1.14B in the quarter ending December 31, 2024, a decrease of -1.61%.
Revenue (ttm)
$4.37B
Revenue Growth
-6.06%
P/S Ratio
0.88
Revenue / Employee
$521,948
Employees
8,379
Market Cap
3.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PRGO News
- 4 weeks ago - Perrigo Company plc (PRGO) 2025 Investor Day (Transcript) - Seeking Alpha
- 4 weeks ago - Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day - PRNewsWire
- 4 weeks ago - 31 Upcoming Dividend Increases, Including 3 Kings - Seeking Alpha
- 4 weeks ago - Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations - PRNewsWire
- 4 weeks ago - Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference - PRNewsWire
- 5 weeks ago - Perrigo Increases Quarterly Dividend by 5% - PRNewsWire
- 7 weeks ago - Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships - PRNewsWire
- 2 months ago - Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025 - PRNewsWire